Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001359821-08-000002

Director bought 4,200 shares at $0.89 ($3,738)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Smith Albert Louis Director 2008-05-19 Purchase +4,200 $0.89 $3,738 122,147 D
Open-market purchases · 4,200 sh · avg $0.89 · $3,738
Loading xslF345X02/primary_doc.xml…